
□ 2021.03-현재 우석대학교 약학대학 조교수
□ 2018.06-2020.08 BronxCare Health System, Bronx, NY, USA, 감염전문약사 및 2년차 감염전공약사 수련 프로그램 책임자
□ 2016.07-2018.05 SUNY Downstate Medical Center, Brooklyn, NY, USA, 감염전문약사 및 2년차 감염전공약사 수련 프로그램 책임자
□ 2016.07-2018.05 Touro College of Pharmacy, New York, NY, USA, 조교수
□ 2013.09-2016.06 Fairleigh Dickinson University, School of Pharmacy and Health Sciences, Florham Park, NJ, USA, 조교수
[전문약사 자격증]
□ 2018.12-현재 Board Certified Infectious Diseases Pharmacist (BCIDP), Board of Pharmacy Specialties (BPS), USA
□ 2014.12-현재 Board Certified Pharmacotherapy Specialist (BCPS), Board of Pharmacy Specialties (BPS), USA
[대표논문]
□ Huggins CE, Park TE, Boateng E, Zeana C. The impact of a standardized discharge process on 30-day readmissions for patients on outpatient parenteral antibiotic treatment. Hosp Pharm 2020; doi.org/10.1177/0018578720985434.
□ Pathickal SM, Park TE, Sharma R. Clinical outcomes associated with the use of anticoagulant and antiplatelet agents in patients undergoing treatment for infective endocarditis: a pilot study. Clin Ther 2020;42(9):1828-38.
□ Ocheretyaner ER, Park TE. Immunologic and virologic responses to antiretroviral therapy in treatment-naïve, HIV-infected elderly patients. Int J STD AIDS 2019;30(13):1304-10.
□ Ocheretyaner ER, Park TE. Delafloxacin: a novel fluoroquinolone with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Expert Rev Anti Infect Ther 2018;16(7):525-30.
□ Ozdener AE, Park TE, Kalabalik J, Gupta R. The future of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection. Expert Rev Anti Infect Ther 2017;15(5):467-81.
□ Park TE, Yusuff J, Sharma R. Use of aspirin and statins for the primary prevention of myocardial infarction and stroke in patients with human immunodeficiency virus infection. Int J STD AIDS 2016;27(6):447-52.
□ Sharma R, Park TE, Moy S. Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination for the treatment of resistant Gram-negative organisms. Clin Ther 2016;38(3):431-44.
□ Park TE, Mohamed A, Kalabalik J, Sharma R. Review of integrase strand transfer inhibitors for the treatment of human immunodeficiency virus infection. Expert Rev Anti Infect Ther 2015;13(10):1195-212.
[저서]
□ Cani E, Park TE, Kavanagh R. Chapter 27 – antiviral drugs. In: Ray SD, ed. Side Effects of Drugs Annual, vol. 41. Elsevier B.V. Cambridge, MA;2019:301-19.
□ Park TE. How steroids work. In: Standora JE, Bogomolnik A, Slugocki M, eds. Steroids: history, science, and issues (the story of a drug). ABC-CLIO, LLC; Santa Barbara, CA;2017:65-75.
[수상]
□ 2019.113rd Place in Original Research, Hospital Day, BronxCare Health System, Bronx, NY, USA □ 2013.09ACCP Infectious Diseases PRN Travel Award, American College of Clinical Pharmacy (ACCP) Infectious Diseases Practice and Research Network (PRN)
□ 2013.02The HIV Pharmacy Research Award, New York State Council of Health-System Pharmacists Research and Education Foundation (NYSCHP-REF)
[학회활동]
□ Infectious Diseases Society of America (IDSA)
□ Society of Infectious Diseases Pharmacists (SIDP)
□ American College of Clinical Pharmacy (ACCP)
□ American Society of Health-System Pharmacists (ASHP)